Abstract: A method for delithiating a lithium and transition metal nitride. The method involves mixing an oxidising agent with the lithium and transition metal nitride and recovering the material obtained. The transition metal may be Mn, Fe, Co, Ni, Cu, or a mixture thereof. The material obtained by the method may be used as a negative electrode material for a lithium-ion battery.

Abstract: A multimedia presentation system for presenting multimedia data comprising a demultiplexing unit and at least one processing unit. The demultiplexing unit demultiplexes a plurality of streams of data. At least one presentation processing unit provides the plurality of stream of data for presentation according to predetermined timing and detecting an end of any one of the plurality of streams of data.

Abstract: Described are computer-based methods and apparatuses, including computer program products, for scalable seamless digital video stream splicing. Data packets in a first video stream of bits are rearranged. Placeholder packets are created in a second video stream of bits. The first video stream of bits and the second video stream of bits are combined to generate a spliced stream by inserting data packets from the first video stream of bits into the placeholder packets in the second video stream of bits.

Abstract: Described are computer-based methods and apparatuses, including computer program products, for scalable seamless digital video stream splicing. Data packets in a first video stream of bits are rearranged. Placeholder packets are created in a second video stream of bits. The first video stream of bits and the second video stream of bits are combined to generate a spliced stream by inserting data packets from the first video stream of bits into the placeholder packets in the second video stream of bits.

Abstract: Novel phenyl compounds, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the compounds are agonists and/or ligands of cannabinoid receptors and may be useful, inter alia, for treating and/or preventing pain, gastrointestinal disorders, genitourinary disorders, inflammation, glaucoma, auto-immune diseases, ischemic conditions, immune-related disorders, and neurodegenerative diseases, for providing cardioprotection against ischemic and reperfusion effects, for inducing apoptosis in malignant cells, and as an appetite stimulant.

Abstract: Novel phenyl compounds, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the compounds are agonists and/or ligands of cannabinoid receptors and may be useful, inter alia, for treating and/or preventing pain, gastrointestinal disorders, genitourinary disorders, inflammation, glaucoma, auto-immune diseases, ischemic conditions, immune-related disorders, and neurodegenerative diseases, for providing cardioprotection against ischemic and reperfusion effects, for inducing apoptosis in malignant cells, and as an appetite stimulant.

Abstract: Spirocyclic heterocyclic derivatives, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the spirocyclic heterocyclic derivatives are ligands of the ? opioid receptor and may be useful, inter alia, for treating and/or preventing pain, anxiety, gastrointestinal disorders, and other ? opioid receptor-mediated conditions.

Abstract: A multimedia presentation system for presenting multimedia data comprising a demultiplexing unit and at least one processing unit. The demultiplexing unit demultiplexes a plurality of streams of data. At least one presentation processing unit provides the plurality of stream of data for presentation according to predetermined timing and detecting an end of any one of the plurality of streams of data.

Abstract: Novel sulfamoyl benzamide compounds, pharmaceutical compositions containing the sulfamoyl benzamide compounds, and methods of their pharmaceutical use are disclosed. In certain embodiments, the sulfamoyl benzamide compounds are agonists and/or modulating ligands of cannabinoid receptors and may be useful, inter alia, for treating and/or preventing pain, gastrointestinal disorders, inflammation, auto-immune diseases, ischemic conditions, immune-related disorders, hypertension, neurological disorders, and neurodegenerative diseases, for providing cardioprotection against ischemic and reperfusion effects, for inducing apoptosis in malignant cells, for inhibiting mechanical hyperalgesia associated with nerve injury, and as an appetite stimulant.

Abstract: Novel phenyl compounds, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the compounds are agonists and/or ligands of cannabinoid receptors and may be useful, inter alia, for treating and/or preventing pain, gastrointestinal disorders, genitourinary disorders, inflammation, glaucoma, auto-immune diseases, ischemic conditions, immune-related disorders, and neurodegenerative diseases, for providing cardioprotection against ischemic and reperfusion effects, for inducing apoptosis in malignant cells, and as an appetite stimulant.